Trastuzumab Deruxtecan in Patients With <i>HER2</i>-Mutant Metastatic Non–Small-Cell Lung Cancer: Primary Results From the Randomized, Phase II DESTINY-Lung02 Trial

Kōichi Goto, Yasushi Goto, Toshio Kubo, +21

Journal of Clinical Oncology

A Phase II Study of Trastuzumab Emtansine in HER2-Positive Non–Small Cell Lung Cancer

Katsuyuki Hotta, Keisuke Aoe, Toshiyuki Kozuki, +12

Journal of Thoracic Oncology

MedicineCancer Cell BiologyPathologyPhase Ii StudyCancer Biology +6

The Japanese Lung Cancer Society Guideline for non-small cell lung cancer, stage IV

Hiroaki Akamatsu, Kiichiro Ninomiya, Hirotsugu Kenmotsu, +30

International Journal of Clinical Oncology

The effect and safety of immune checkpoint inhibitor rechallenge in non-small cell lung cancer

Hiromi Watanabe, Toshio Kubo, Kiichiro Ninomiya, +14

Japanese Journal of Clinical Oncology

VEGFR2 blockade augments the effects of tyrosine kinase inhibitors by inhibiting angiogenesis and oncogenic signaling in oncogene‐driven non‐small‐cell lung cancers

Hiromi Watanabe, Eiki Ichihara, Hiroe Kayatani, +19

Cancer Science

MET or NRAS amplification is an acquired resistance mechanism to the third-generation EGFR inhibitor naquotinib

Kiichiro Ninomiya, Kadoaki Ohashi, Go Makimoto, +10

Scientific Reports

ImmunologyPharmacotherapyCancer BiologyTumor BiologyDrug Resistance +17

A suspected case of rocuronium–sugammadex complex-induced anaphylactic shock after cesarean section

Masakazu Yamaoka, Miki Deguchi, Kiichiro Ninomiya, +2

Journal of Anesthesia

Congestive Heart Failure During Osimertinib Treatment for Epidermal Growth Factor Receptor (EGFR)-mutant Non-small Cell Lung Cancer (NSCLC)

Hiromi Watanabe, Eiki Ichihara, Hirohisa Kano, +3

Internal Medicine

Tumor BiologyCardiomyopathyHeart FailureMedicineOsimertinib Treatment +12

A Prospective Cohort Study to Define the Clinical Features and Outcome of Lung Cancers Harboring HER2 Aberration in Japan (HER2-CS STUDY)

Kiichiro Ninomiya, Tae Hata, Hiroshige Yoshioka, +128

CHEST Journal

Cancer EpidemiologyMedicineEpidemiology Of CancerPathologyClinical Features +7

Clinical significance of repeat rebiopsy in detecting the EGFR T790M secondary mutation in patients with non-small cell lung cancer

Eiki Ichihara, Katsuyuki Hotta, Toshio Kubo, +6

Oncotarget